miDIAGNOSTICS is a developer of integrated diagnostic solutions for on-chip detection of cells, proteins, nucleic acids and small molecules.
$31.5M
Dec 03, 2024
-
CytoReason is an Israel-based biotechnology company that develops computational disease models and drug development for the treatment of cancer and inflammatory diseases.
$80M
Jul 16, 2024
-
IONpath is a California-based biotechnology company that develops products such as conjugated antibodies and reagents for sectors including biotech and life sciences.
-
May 10, 2022
-
WuXi Diagnostics is a clinical decision-making platform that provides disease screening and drug monitoring solutions for healthcare providers.
$150M
Feb 22, 2021
-
OncoNano is a Texas-based biotechnology company that researches and develops T cell-based immunotherapies for the treatment of cancer.
$49.1M
Oct 14, 2020
-
Frequently Asked Questions about Thermo Fisher Scientific
What is Thermo Fisher Scientific investing in?
Thermo Fisher Scientific has invested in 7 companies including miDiagnostics, CytoReason and IONpath
What company did Thermo Fisher Scientific invest in?
Thermo Fisher Scientific invested in a total 7 companies including miDiagnostics, CytoReason and IONpath
What are the top 5 investments by Thermo Fisher Scientific?
The top companies in which Thermo Fisher Scientific invested are miDiagnostics, CytoReason, IONpath, WuXi Diagnostics and OncoNano
